We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4203:TSESumitomo Bakelite Co., Ltd. Analysis

Data as of 2026-06-07 - not real-time

¥6,510.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sumitomo Bakelite is trading above its discounted cash‑flow estimate yet below analyst median targets, indicating a modest premium. The 20‑day SMA sits above the current price while the 50‑day and 200‑day SMAs remain below, suggesting mixed short‑term momentum. RSI resides in the mid‑fifties, pointing to neither overbought nor oversold conditions. MACD shows a bearish crossover with a negative histogram, adding pressure on the near‑term price. Nevertheless, the broader trend is flagged bullish and volatility is elevated, reflecting active price swings. The stock’s beta near one implies market‑aligned risk. Fundamentals reveal solid revenue growth and healthy operating margins. Earnings per share remain robust, and the forward PE is higher than trailing, indicating expectations of slower earnings acceleration. The dividend yield is modest with a payout ratio comfortably below the threshold, appearing sustainable given strong cash generation. Debt levels are modest relative to cash, keeping leverage low. The Fear & Greed index sits in the “Extreme Greed” zone, hinting at bullish sentiment but also potential over‑optimism. Considering these factors, the stock presents a balanced profile with upside potential if valuation compresses, yet caution is warranted given technical bearish signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover
  • Price below short‑term SMA
  • Elevated volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and margins
  • Sustainable dividend
  • Potential valuation compression toward fair value

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable cash generation and low leverage
  • Consistent dividend policy
  • Broad market‑aligned beta with moderate sector risk

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin8.76%
P/E Ratio20.4
ROE8.81%
ROA4.92%
Debt/Equity7.80
P/B Ratio1.6
Op. Cash Flow¥35.0B
Free Cash Flow¥12.6B

Technical Analysis

TrendBullish
RSI55.0
Support¥5,468.00
Resistance¥7,108.00
MA 20¥6,637.20
MA 50¥5,769.56
MA 200¥5,329.74
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Fair Value¥4,159.53
Target Price¥6,603.33
Upside/Downside1.43%
GradeOvervalued
TypeGrowth
Dividend Yield1.84%

Risk Assessment

Beta0.95
Volatility49.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.